Paroxysmal nocturnal haemoglobinuria - eculizumab or ravulizumab - continuing authority application form (PB328)

Use this form to apply to continue PBS-subsidised treatment with eculizumab or ravulizumab for paroxysmal nocturnal haemoglobinuria.

Page last updated: 1 December 2024.
QC 62062